Ledger.Open graph →
SEC Form D · filed May 10, 2021

CeleCor Therapeutics, Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DEL MAR, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Robert S. Hillman · San Diego, CAExec · DirectorJack B. Lief · Del Mar, CADirectorPeter B. Finn · Boston, MAExecAndreas B. Ritzi · Del Mar, CADirectorSteven W. Davis · Birmingham, ALExecPeter B. Finn · Boston, MAExec · DirectorBenjamin Fogle · West Des Moines, IADirectorSusan Webb · New York, NYExec · DirectorMatthew Kennedy · New York, NYExecPaul J. Newfield · Wellington, Q2DirectorAndreas B. Ritzi · Del Mar, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗